AMPH Quote, Trading Chart, Amphastar Pharmaceuticals Inc.
home / stock / amph / amph quote
$17.51 Last:
1.74% Change Percent:
$17.3341 Open:
$17.51 Previous Close:
$17.55 High:
$17.115 Low:
106,710 Volume:
03/05/2021 01:55:15 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-05 | 17.3341 | 17.51 | 17.55 | 17.115 | 106,710 |
| 2021-03-04 | 17.7 | 17.21 | 17.8 | 17.17 | 199,607 |
| 2021-03-03 | 17.48 | 17.78 | 17.86 | 17.2 | 212,036 |
| 2021-03-02 | 17.44 | 17.37 | 17.73 | 17.15 | 1,418,808 |
| 2021-03-01 | 17.79 | 17.48 | 18.03 | 17.41 | 304,371 |
| 2021-02-26 | 17.55 | 17.53 | 17.89 | 17.31 | 388,616 |
| 2021-02-25 | 18.22 | 17.89 | 18.45 | 17.858 | 121,250 |
| 2021-02-24 | 17.96 | 18.35 | 18.45 | 17.85 | 128,479 |
| 2021-02-23 | 18.05 | 17.77 | 18.22 | 17.66 | 176,418 |
| 2021-02-22 | 18.35 | 18.11 | 18.37 | 18.04 | 178,457 |
| 2021-02-19 | 18.31 | 18.475 | 18.6 | 18.29 | 352,904 |
| 2021-02-18 | 18.57 | 18.35 | 18.76 | 18.33 | 153,973 |
| 2021-02-17 | 18.4 | 18.7 | 18.86 | 18.3 | 114,158 |
| 2021-02-16 | 18.86 | 18.41 | 18.96 | 18.4 | 166,937 |
| 2021-02-15 | 19.11 | 18.88 | 19.18 | 18.84 | 113,319 |
| 2021-02-12 | 19.11 | 18.88 | 19.18 | 18.84 | 113,119 |
| 2021-02-11 | 18.9 | 19.14 | 19.21 | 18.75 | 173,120 |
| 2021-02-10 | 18.91 | 18.83 | 18.935 | 18.48 | 135,712 |
| 2021-02-09 | 18.93 | 18.93 | 19.11 | 18.71 | 100,706 |
| 2021-02-08 | 19.08 | 18.86 | 19.18 | 18.68 | 125,944 |
Amphastar Pharmaceuticals Inc. Company Name:
AMPH Stock Symbol:
NASDAQ Market:
Amphastar Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
RANCHO CUCAMONGA, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, V.P of Corporate Communications and HR, Tony Marrs, Sr. V.P Regulatory Affairs and Clinical Operations, and Jacob Liawatidewi, Exec...
-
RANCHO CUCAMONGA, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) has approved its Abbreviated New Drug Application (“ANDA”) for Glucagon for Injectio...
-
Image source: The Motley Fool. Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Q3 2020 Earnings Call Nov 6, 2020 , 12:00 p.m. ET Operator Continue reading For further details see: Amphastar Pharmaceuticals Inc (AMPH) Q3 2020 Earnings Call Tr...